Vitamin K Antagonists: Beyond bleeding

Seminars in Dialysis

Volumn 27, Issue 1, 2014, Pages 37-41

  Krüger, Thilo ^a   Floege, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP;

ARTICLE; BLEEDING; BLOOD VESSEL CALCIFICATION; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MONITORING; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE, CHRONIC; RENAL INSUFFICIENCY, CHRONIC; VASCULAR CALCIFICATION; VENOUS THROMBOEMBOLISM; VITAMIN K;

EID: 84892158566     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12175     Document Type: Article

References (57)

1. Winkelmayer WC, Levin R, Avorn J: Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. Am J Kidney Dis 41:84-89, 2003
2. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
3. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE: Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927-1936, 2001
4. Ocak G, van Stralen KJ, Rosendaal FR: Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. J Thromb Haemost 10:2484-2493, 2012
5. Ocak G, Vossen CY, Rotmans JI: Venous and arterial thrombosis in dialysis patients. Thromb Haemost 106:1046-1052, 2011
6. Thomson BK, MacRae JM, Barnieh L: Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients. BMC Nephrol 12:46, 2011
7. Abe M, Maruyama N, Suzuki H, Okada K, Soma M: International normalized ratio decreases after hemodialysis treatment in patients treated with warfarin. J Cardiovasc Pharmacol 60:502-507, 2012
8. Soliman EZ, Prineas RJ, Go AS: Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J 159:1102-1107, 2010
9. Wizemann V, Tong L, Satayathum S: Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 77:1098-1106, 2010
10. Iguchi Y, Kimura K, Kobayashi K: Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 102:1056-1059, 2008
11. Hart RG, Pearce LA, Asinger RW, Herzog CA: Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol 6:2599-2604, 2011
12. Genovesi S, Vincenti A, Rossi E: Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 51:255-262, 2008
13. Herzog CA, Asinger RW, Berger AK: Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80:572-586, 2011
14. To AC, Yehia M, Collins JF: Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply? Nephrology (Carlton) 12:441-447, 2007
15. Knoll F, Sturm G, Lamina C: Coumarins and survival in incident dialysis patients. Nephrol Dial Transplant 27:332-337, 2012
16. Vazquez E, Sanchez-Perales C, Garcia-Garcia F: Atrial fibrillation in incident dialysis patients. Kidney Int 76:324-330, 2009
17. Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK: Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 6:2662-2668, 2011
18. Olesen JB, Lip GY, Kamper AL: Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367:625-635, 2012
19. Schlieper G, Kruger T, Floege J: Atrial fibrillation and chronic kidney disease. N Engl J Med 367:2157-2159, 2012
20. Luo G, Ducy P, McKee MD: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81, 1997
21. Meier M, Weng LP, Alexandrakis E, Ruschoff J, Goeckenjan G: Tracheobronchial stenosis in Keutel syndrome. Eur Respir J 17:566-569, 2001
22. Schurgers LJ, Teunissen KJ, Knapen MH: Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25:1629-1633, 2005
23. Price PA, Faus SA, Williamson MK: Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18:1400-1407, 1998
24. Kruger T, Oelenberg S, Kaesler N: Warfarin induces cardiovascular damage in mice. Arterioscler Thromb Vasc Biol 33:2618-2624, 2013
25. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C: Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109:2823-2831, 2007
26. Koos R, Mahnken AH, Muhlenbruch G: Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol 96:747-749, 2005
27. Koos R, Krueger T, Westenfeld R: Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 101:706-713, 2009
28. Holden RM, Sanfilippo AS, Hopman WM, Zimmerman D, Garland JS, Morton AR: Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol 20:417-422, 2007
29. Brandenburg VM, Cozzolino M, Ketteler M: Calciphylaxis: a still unmet challenge. J Nephrol 24:142-148, 2011
30. Hayashi M, Takamatsu I, Kanno Y, Yoshida T, Abe T, Sato Y: A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 27:1580-1584, 2012
31. Shea MK, O'Donnell CJ, Vermeer C: Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 141:1529-1534, 2011
32. Westenfeld R, Krueger T, Schlieper G: Effect of vitamin K(2) supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 59:186-195, 2012
33. Cranenburg EC, Schurgers LJ, Uiterwijk HH: Vitamin K intake and status are low in hemodialysis patients. Kidney Int 82:605-610, 2012
34. Schlieper G, Westenfeld R, Kruger T: Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 22:387-395, 2011
35. Wan Y, Heneghan C, Perera R: Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 1:84-91, 2008
36. Chan KE, Lazarus JM, Thadhani R, Hakim RM: Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 20:2223-2233, 2009
37. Phelan PJ, O'Kelly P, Holian J: Warfarin use in hemodialysis patients: what is the risk? Clin Nephrol 75:204-211, 2011
38. Limdi NA, Limdi MA, Cavallari L: Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis 56:823-831, 2010
39. Limdi NA, Beasley TM, Baird MF: Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 20:912-921, 2009
40. Maruyama N, Abe M, Okada K, Soma M: Changes to prothrombin international normalized ratio in patients receiving hemodialysis. Int J Clin Pharmacol Ther 51:283-287, 2013
41. Rioux JP, De BB, Querin S, Deziel C, Troyanov S, Madore F: Measurement of the international normalized ratio (INR) in hemodialysis patients with heparin-locked central venous catheters: evaluation of a novel blood sampling method. J Vasc Access 10:180-182, 2009
42. Rombouts EK, Rosendaal FR, Van Der Meer FJ: Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 5:2043-2048, 2007
43. Sood MM, Rigatto C, Bueti J: Thrice weekly warfarin administration in haemodialysis patients. Nephrol Dial Transplant 24:3162-3167, 2009
44. Chang MC, Wang TM, Yeung SY: Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Atherosclerosis 219:559-565, 2011
45. Yagmur E, Frank RD, Neulen J, Floege J, Muhlfeld AS: Platelet hyperaggregability is highly prevalent in patients with chronic kidney disease: an underestimated risk indicator of thromboembolic events. Clin Appl Thromb Hemost 2013 May 31 [Epub ahead of print]
46. Camm AJ, Kirchhof P, Lip GY: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360-1420, 2010
47. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005;45:S1-S153
48. Zellweger M, Bouchard J, Raymond-Carrier S, Laforest-Renald A, Querin S, Madore F: Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J 51:360-365, 2005
49. Coli L, Donati G, Cianciolo G: Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. J Vasc Access 7:118-122, 2006
50. Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW: Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 40:1255-1263, 2002
51. Wilkieson TJ, Ingram AJ, Crowther MA: Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial. Clin J Am Soc Nephrol 6:1018-1024, 2011
52. Willms L, Vercaigne LM: Does warfarin safely prevent clotting of hemodialysis catheters? a review of efficacy and safety. Semin Dial 21:71-77, 2008
53. Traynor JP, Walbaum D, Woo YM, Teenan P, Fox JG, Mactier RA: Low-dose warfarin fails to prolong survival of dual lumen venous dialysis catheters. Nephrol Dial Transplant 16:645, 2001
54. Crowther MA, Clase CM, Margetts PJ: Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol 13:2331-2337, 2002
55. Kruger T, Brandenburg V, Schlieper G, Marx N, Floege J: Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients. Nephrol Dial Transplant 28:534-541, 2013
56. Genovesi S, Santoro A: Anticoagulants, renal failure and atrial fibrillation. Expert Opin Drug Saf 12:1-3, 2013
57. Ahmad Y, Lip GY: Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation. Contrib Nephrol 179:81-91, 2013